Metraipolis › archive › dc_c49b8b19fc86

MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA — Europe PMC PMID:41369417

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41369417
DOI
10.3390/cells14231928
License (as archived)
solo-consultazione
Archived
2026-11-07T22:14:12.911Z
SHA-256 of the archived text
c2b04056a67de0677e5b4f710df75e82517f92ab2c08a5c733aed1f35c517107
Stable URL of this page
https://metraipolis.com/documento/dc_c49b8b19fc86

How to cite

MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA — Europe PMC PMID:41369417 — Europe PMC (en), https://europepmc.org/article/MED/41369417 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c49b8b19fc86 (Metraipolis archive dc_c49b8b19fc86, sha256 c2b04056a67de0677e5b4f710df75e82517f92ab2c08a5c733aed1f35c517107)
BibTeX
@misc{dcc49b8b19fc86,
  title = {MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA — Europe PMC PMID:41369417},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41369417},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c49b8b19fc86; sha256 c2b04056a67de0677e5b4f710df75e82517f92ab2c08a5c733aed1f35c517107},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41369417. Agents can read the archived copy with the MCP tool read_document.